$PL

Morgan Stanley Adjusts Planet Labs PBC Price Target to $19 From $35

Morgan Stanley reduced its price target for Planet Labs PBC from $35 to $19. The company's stock is currently trading at $14.54, up 2.90% in pre-market. Planet Labs recently won a satellite services tender from the German government.

Original reporting
Published Oct 16, 2026, 12:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 1:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$PL
Bearish
high confidence
Mentioned
$PL
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$PLBearishMed
01

Why it matters

The target reduction may trigger short covering or sell pressure.

02

Market read

Analyst downgrade could influence short-term price action for PL.

03

What to watch

Recent contract wins or technology advancements not reflected in the target.

Relevance 6/10Novelty 6/10Timing: pre-market today

Background

Morgan Stanley's research note revises Planet Labs' valuation amid recent market conditions.

Company-level read

Ticker impact

$PLBearishHigh confidence
Context

Morgan Stanley cut Planet Labs' price target to $19 from $35, indicating a bearish outlook.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Target cut of nearly 50% signals reduced valuation expectations.

Market effects

Potential drag on space and satellite services sector as analysts reassess valuations.

Minimal regional effect; primarily US-listed investors affected.

Limited global impact beyond Planet Labs exposure.

Counterpoint

Some investors may view the steep cut as an overreaction and see upside potential.

Key entities

  • Planet Labs PBC

    U.S.-listed satellite imagery provider.

  • Morgan Stanley

    Equity research provider issuing the target change.

Related articles

$SPCXMed

SPCX Stock Outperforms Space Peers This Week As RKLB, ASTS, RDW And PL Slide

SpaceX (SPCX) gained 1% this week, while peers like Redwire (RDW), Rocket Lab (RKLB), AST SpaceMobile (ASTS), and Planet Labs (PL) declined. SpaceX acquired Grain Management's spectrum for $8B, pending FCC approval, and secured a deal with American Airlines for Starlink. Up to 328.4M SPCX shares may become eligible for sale on Friday. Other companies reported mixed operational updates and market sentiment.

$PLHigh

Effective Satellite Investment Amid High Multiples for Launch Peers – SatNews

Planet Labs PBC is highlighted as a lower-multiple investment in the commercial space sector, trading at 14.6x price-to-sales, compared to 96x for SpaceX and 55x for Rocket Lab. It reported Q2 revenue of $116.1M, up 58% YoY, with a 57% gross margin and positive free cash flow. Defense revenue surged over 90% YoY, but shares are down 18.15% YTD. Analysts rate it a 'Strong Buy' with a $34.78 target, implying 99% upside.